Eliem Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 98.65% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
49.5%	RA Capital Management, L.P.	13,150,849	$44.8m	0%	0.77%
18.86%	Ai Eti Llc	5,009,400	$17.1m	0%	no data
7.54%	Intermediate Capital Group plc	2,002,563	$6.8m	0%	100%
6.49%	BML Capital Management, LLC	1,723,729	$5.9m	0%	5.25%
5.5%	LifeArc, Endowment Arm	1,461,538	$5.0m	0%	no data
3.17%	Farringdon Capital Management	841,087	$2.9m	0%	1.45%
1.51%	Silverarc Capital Management, LLC	402,088	$1.4m	-43.61%	0.49%
1.31%	Driehaus Capital Management LLC	348,571	$1.2m	0%	0.01%
1.03%	The Vanguard Group, Inc.	274,392	$934.9k	0%	no data
0.85%	Woodline Partners LP	226,604	$772.0k	-39.31%	0.01%
0.67%	Adam Rosenberg	178,100	$606.8k	0%	no data
0.57%	Valerie Morisset	150,322	$512.1k	0%	no data
0.27%	Millennium Management LLC	72,065	$245.5k	-19.88%	no data
0.25%	Atom Investors LP	67,074	$228.5k	154.95%	0.07%
0.24%	Geode Capital Management, LLC	64,139	$218.5k	0%	no data
0.21%	Bridgeway Capital Management, LLC	55,223	$188.1k	170.4%	no data
0.12%	BlackRock, Inc.	31,871	$108.6k	-1.29%	no data
0.12%	Tudor Investment Corporation	30,619	$104.3k	0%	no data
0.095%	BMO Asset Management Corp.	25,244	$86.0k	0%	no data
0.075%	State Street Global Advisors, Inc.	19,800	$67.5k	0%	no data
0.068%	Chicago Partners Investment Group LLC	18,179	$61.9k	-23.18%	no data
0.061%	Stifel Asset Management Corp.	16,162	$55.1k	25.97%	no data
0.059%	Braden Leonard	15,649	$53.3k	0%	no data
0.044%	Citadel Advisors LLC	11,587	$39.5k	-23.82%	no data
0.043%	Northern Trust Global Investments	11,494	$39.2k	0%	no data